Insmed Targets $5bn-Plus Market With Brinsupri For Bronchiectasis

First Approval For Disease And Drug Mechanism

 
• By Mandy Jackson
  
Brensocatib approvals for bronchiectasis are pending in the EU and UK (Shutterstock)

More from New Products

More from Scrip